Masimo SET ® helped significantly reduce rates of severe retinopathy of prematurity (ROP) and the need for laser treatment. 1 Masimo SET ® enabled pulse oximetry screening for critical congenital ...
Masimo’s NeoPODS study in critically ill newborns found its SET pulse oximetry technology delivered consistent accuracy across all skin tones, with less than 1% bias. The findings address longstanding ...
Improved SpO 2 Accuracy Now Available for All Patient Populations IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that RD SET ® sensors with Masimo Measure-through Motion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results